Skip to content
Innovex Therapeutics Innovex Therapeutics
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us
Innovex Therapeutics Innovex Therapeutics
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us
  • Home
  • R&D
    • Vaccine against Plasmodium vivax malaria
    • Vaccine against Covid-19
    • Vaccine against PRRSV
  • About Us
    • The company
    • Our Story
    • The Team
    • Advisory board
  • News
  • Contact Us

New shareholders

Lorenzo José Fraile y Maria Montoya have recently joined ITSL as a new shareholders

Continue reading

Recent Posts

  • The Plasmodium vivax malaria project of ITSL elected as part the fund’s portfolio of the EU Malaria Fund
  • Plasmodium vivax: the Neglected Malaria
  • Dr. Agustin Arasanz Duque named new Interim CEO of ITSL
  • RIS3CAT Project
  • New shareholders

Recent Comments

    Search Content

    Navigation

    • Home
    • R&D
      • Vaccine against Plasmodium vivax malaria
      • Vaccine against Covid-19
      • Vaccine against PRRSV
    • About Us
      • The company
      • Our Story
      • The Team
      • Advisory board
    • News
    • Contact Us

    Today’s Choice

    Follow Us

    DribbbleSpotifySteamWeiboPinterest
    Innovex Therapeutics Innovex Therapeutics
    Innovex Therapeutics S.L. is a biotechnology company that uses Extracellular Vesicles as Vaccines against infectious diseases with the goal of global health equity.
    Linkedin